首页 > 市场调查报告书 > 製药

处方药疼痛

市场调查报告书

商品编码

1619197

镇痛药市场规模、份额、成长分析，按药物类型、给药途径、应用、分销管道、地区 - 行业预测，2024-2031

Analgesics Market Size, Share, Growth Analysis, By Drug Type (Opioid Analgesics, Morphine), By Route Of Administration (Oral, Tablets), By Application, By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球镇痛药市场规模为386亿美元，从2023年的409.2亿美元成长到2031年的652.1亿美元，复合年增长率预计为6.0%。

全球镇痛药市场在慢性疼痛发病率上升、老年人口扩大以及对疼痛管理策略的认识不断增强等关键洞察的推动下持续增长。因此，对于缓解疼痛和不适至关重要的止痛药的需求不断增加，无论是处方药还是非处方药。药物输送系统的创新、新型镇痛製剂的推出以及学名药供应的增加继续刺激市场扩张。此外，行业领先公司之间的策略联盟、併购旨在加强产品系列併扩大我们在镇痛药领域的全球影响力。总体而言，这些因素支持未来几年镇痛药市场的强劲前景。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline plc（GSK）
Sanofi SA
Bayer AG
Novartis AG
Merck & Co., Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
AbbVie Inc.
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Mylan NV
Endo Pharmaceuticals Inc.
Purdue Pharma LP
Mallinckrodt Pharmaceuticals
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Zydus Cadila

结论和建议

简介目录

Product Code: SQMIG35I2164

Global Analgesics Market size was valued at USD 38.6 billion in 2022 and is poised to grow from USD 40.92 billion in 2023 to USD 65.21 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

The global analgesics market is experiencing consistent growth, propelled by key insights such as the rising incidence of chronic pain, an expanding elderly demographic, and heightened awareness surrounding pain management strategies. This has led to increased demand for both prescription and over-the-counter analgesic drugs, essential for alleviating pain and discomfort. Innovations in drug delivery systems, the launch of novel analgesic formulations, and a rising availability of generic alternatives continue to stimulate market expansion. Furthermore, strategic partnerships, mergers, and acquisitions among leading industry players are aimed at enhancing product portfolios and broadening their global presence in the analgesics sector. Overall, these factors collectively underpin the robust outlook for the analgesics market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Analgesics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Analgesics Market Segmental Analysis

Global Analgesics Market is segmented by drug type, route of administration, application, distribution channel and region. Based on drug type, the market is segmented into opioid analgesics and non-opioid analgesics. Based on route of administration, the market is segmented into oral, topical, injectable and transdermal. Based on application, the market is segmented into chronic pain, acute pain and other. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Analgesics Market

One of the key factors propelling the global analgesics market is the rising incidence of chronic pain conditions among the population. A considerable number of individuals experience chronic pain from ailments such as arthritis, cancer, neuropathic pain, and musculoskeletal disorders, which escalates the demand for effective pain management solutions. This persistent need for relief demands innovative analgesic drugs that enhance patients' quality of life. Furthermore, increasing awareness surrounding pain management techniques and ongoing advancements in pharmaceutical research contribute to the development of new and improved analgesics, playing a significant role in driving market expansion and catering to the growing needs of pain sufferers globally.

Restraints in the Global Analgesics Market

A significant challenge facing the global analgesics market is the inherent risk of side effects and the potential for abuse associated with certain analgesic medications. Opioid analgesics are particularly problematic due to their association with dependence, addiction, and the risk of overdose, contributing to widespread public health issues. Consequently, there has been growing regulatory scrutiny, resulting in the implementation of stricter prescribing guidelines for these medications. Healthcare providers are exercising increased caution in prescribing and monitoring opioids, which has prompted a shift toward non-opioid alternatives and other pain management strategies. This balancing act between providing effective pain relief and mitigating abuse risks hampers the market's overall growth.

Market Trends of the Global Analgesics Market

A significant trend in the global analgesics market is the escalating demand for non-opioid analgesics, driven by increasing awareness about the risks associated with opioid use, including addiction and overdose. This shift is prompting healthcare professionals and consumers alike to seek safer alternatives for pain management. Non-opioid options, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are emerging as preferred choices for treating mild to moderate pain, thereby reshaping the market landscape. As a result, pharmaceutical companies are investing in innovative formulations and research aimed at enhancing the efficacy and safety profiles of non-opioid analgesics to meet this evolving demand.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Startup Analysis

Global Analgesics Market Size by Drug Type & CAGR (2024-2031)

Market Overview
Opioid Analgesics
- Morphine
- Fentanyl
- Oxycodone
- Hydrocodone
Non-Opioid Analgesics
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Ibuprofen
- Naproxen
- Aspirin
- Acetaminophen
- Compound Analgesics

Global Analgesics Market Size by Route Of Administration & CAGR (2024-2031)

Market Overview
Oral
- Tablets
- Capsules
- Liquids
Topical
- Creams
- Gels
- Patches
Injectable
- Intravenous
- Intramuscular
Transdermal

Global Analgesics Market Size by Application & CAGR (2024-2031)

Market Overview
Chronic Pain
- Arthritis
- Cancer Pain
- Neuropathic Pain
Acute Pain
- Postoperative Pain
- Injury Pain
Other
- Migraine
- Fibromyalgia

Global Analgesics Market Size by Distribution Channel & CAGR (2024-2031)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Analgesics Market Size & CAGR (2024-2031)

North America (Drug Type, Route Of Administration, Application, Distribution Channel)
- USA
- Canada
Europe (Drug Type, Route Of Administration, Application, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Drug Type, Route Of Administration, Application, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Drug Type, Route Of Administration, Application, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Drug Type, Route Of Administration, Application, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (GSK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Purdue Pharma L.P.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Therapeutics plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Cadila
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments